Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME Other stock markets 11:43:12 2026-07-24 am EDT			5-day change	1st Jan Change
58.80 ^EUR	+1.20%		+8.59%	-7.40%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.42B	BBB
ELI LILLY AND COMPANY	1,067B	A
JOHNSON & JOHNSON	635B	BBB
ABBVIE INC.	458B	AA	-
ROCHE HOLDING AG	347B	AA
NOVARTIS AG	295B	AAA
ASTRAZENECA PLC	262B	A
NOVO NORDISK A/S	216B	A
AMGEN INC.	203B	A
GILEAD SCIENCES, INC.	161B	AA
PFIZER INC.	140B	A
BRISTOL-MYERS SQUIBB COMPANY	127B	A
VERTEX PHARMACEUTICALS INCORPORATED	121B	AA
SANOFI	104B	AA
GSK PLC	102B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.54B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.09B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.08B	AA
BAYER AG	51.52B	AA
HALEON PLC	42.72B	AA
Average	225.84B	AA
Weighted average by Cap.		AA